Shell Asset Management CO Corcept Therapeutics Inc Transaction History
Shell Asset Management CO
- $2.11 Billion
- Q1 2025
A detailed history of Shell Asset Management CO transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Shell Asset Management CO holds 3,830 shares of CORT stock, worth $264,308. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,830
Previous 8,510
54.99%
Holding current value
$264,308
Previous $429,000
1.86%
% of portfolio
0.02%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding CORT
# of Institutions
477Shares Held
84MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.14 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$689 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$534 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$424 Million1.13% of portfolio
-
Parallel Advisors, LLC3.97MShares$274 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.39B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...